计算溶液所需的质量、体积或浓度。
这是演示店铺,请务下单付款,避免造成你的财物损失。
为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
C124965-1mg |
1mg | 现货 | | |
C124965-5mg |
5mg | 现货 | | |
C124965-10mg |
10mg | 现货 | | |
C124965-50mg |
50mg | 现货 | | |
C124965-100mg |
100mg | 现货 | |
英文别名 | SB 207499;cis-4-Cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid |
---|---|
规格或纯度 | ≥98% |
英文名称 | Cilomilast |
生化机理 |
Cilomilast(Ariflo, SB-207499) is among the first of a new generation of PDE4 inhibitors (Ki ≈100 nM). Cilomilast (SB-207499) inhibits HPDE4 and LPDE4 catalytic activity with equal potency (Ki ≈100 nM). SB-207499 and rolipram are equipotent against LPDE4, but Cilomilast (Ariflo, SB-207499) is 100-fold less potent against HPDE4. This profile sμggests that Cilomilast (Ariflo, SB-207499) retain the anti-inflammatory activity of rolipram yet have a decreased tendency to produce side effects. |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
PubChem SID | 488188235 |
---|---|
IUPAC Name | 4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane-1-carboxylic acid |
INCHI | InChI=1S/C20H25NO4/c1-24-17-7-6-15(12-18(17)25-16-4-2-3-5-16)20(13-21)10-8-14(9-11-20)19(22)23/h6-7,12,14,16H,2-5,8-11H2,1H3,(H,22,23) |
InChi Key | CFBUZOUXXHZCFB-UHFFFAOYSA-N |
Canonical SMILES | COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3 |
WGK Germany | 3 |
PubChem CID | 151170 |
分子量 | 343.42 |
CAS Registry No. | 153259-65-5 |
---|---|
ChEMBL Ligand | CHEMBL511115 |
Wikipedia | Cilomilast |
PubChem CID | 151170 |
RCSB PDB Ligand | CIO |
PubChem SID | 488188235 |
溶解性 | DMSO 69 mg/mL Water <1 mg/mL Ethanol 50 mg/mL |
---|
WGK Germany | 3 |
---|
输入批号以搜索COA:
1. Barnette MS, Christensen SB, Essayan DM, Grous M, Prabhakar U, Rush JA, Kagey-Sobotka A, Torphy TJ. (1998) SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.. J Pharmacol Exp Ther, 284 (1): (420-6). [PMID:9435206] |
2. Griswold DE, Webb EF, Badger AM, Gorycki PD, Levandoski PA, Barnette MA, Grous M, Christensen S, Torphy TJ. (1998) SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.. J Pharmacol Exp Ther, 287 (2): (705-11). [PMID:9808700] |